UK-based sports-nutrition business Applied Nutrition said today (26 August) its underlying annual earnings are set to come in above market expectations.
In a trading update, the food-and-drinks group said its board expects its “adjusted EBITDA to be ahead of consensus market expectations” for the 2026 financial year, increasing by 40% year-on-year to approximately £43.3m.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The figure excludes the impact of the acquisition of assets from US-based sports nutrition manufacturer Nutrablend Group, a deal announced in June.
City analysts were forecasting Applied Nutrition’s adjusted EBITDA for the year to the end of July would come in at £42m.
The company also said today it expects its revenue for the year will grow 50% to £160m, ahead of market forecasts of £148.4m.
Applied Nutrition said today trading from 1 June had remained “strong with sustained demand across the group’s markets and channels”.
For the year ending July 2027, the company expects adjusted EBITDA of about £49m, representing growth of 13%, against consensus of £47.7m.
Revenue for the year is projected at roughly £205m, beating market forecasts of £186.2m, it said.
Applied Nutrition’s share price was up over 8% to 348.5p in early morning trading UK-time today (26 August) before receding to settle at around 323p as of 13:34 BST.
However, “significantly higher” whey protein costs are expected to hit margins, the protein powder and RTD beverages producer said, adding it expects its EBITDA margin for its 2027 fiscal year will likely decline “slightly” from the previous year.
The London-listed business is set to release full-year figures on or around 16 November.
Applied Nutrition company sells products under its namesake brand, as well as ABE, BodyFuel, and Endurance brands.
Across those ranges, it offers more than 120 products and distributes its products in more than 85 countries.
In June, the group paid $16m in cash to acquire the majority of the assets of Nutrablend Group.
The transaction included a freehold, “fully fitted-out” manufacturing and logistics site in Buffalo, New York. Nutrablend’s two in-house supplement brands, Basic Supplements and GR8 Lifestyle, were also included in the transaction.
